This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
このページの翻訳は実験的なもので、現在開発中です。お待ちしております
ISR 株式概要
ISR Immune System Regulation Holding AB (publ) develops immunostimulatory drugs to treat chronic infectious diseases and cancer in Sweden.
ISR Immune System Regulation Holding AB (publ) 競合他社
価格と性能
| 過去の株価 | |
|---|---|
| 現在の株価 | SEK 1.40 |
| 52週高値 | SEK 8.60 |
| 52週安値 | SEK 1.19 |
| ベータ | 0.45 |
| 11ヶ月の変化 | 0% |
| 3ヶ月変化 | 0% |
| 1年変化 | -74.45% |
| 33年間の変化 | -50.70% |
| 5年間の変化 | -86.21% |
| IPOからの変化 | -86.98% |
最新ニュース
Recent updates
We're Not Very Worried About ISR Immune System Regulation Holding's (STO:ISR) Cash Burn Rate
Aug 11
A Look At The Fair Value Of ISR Immune System Regulation Holding AB (publ) (STO:ISR)
Jul 02Is ISR Immune System Regulation Holding (STO:ISR) In A Good Position To Deliver On Growth Plans?
Mar 08Is ISR Immune System Regulation Holding (STO:ISR) In A Good Position To Deliver On Growth Plans?
Nov 18Is ISR Immune System Regulation Holding (STO:ISR) In A Good Position To Deliver On Growth Plans?
Jul 27Here's Why We're Watching ISR Immune System Regulation Holding's (STO:ISR) Cash Burn Situation
Mar 26We Think ISR Immune System Regulation Holding (STO:ISR) Can Afford To Drive Business Growth
Dec 11
株主還元
| ISR | SE Biotechs | SE 市場 | |
|---|---|---|---|
| 7D | 0% | 3.5% | -0.2% |
| 1Y | -74.5% | 36.9% | 28.4% |
業界別リターン: ISR underperformed the Swedish Biotechs industry which returned 4% over the past year.
リターン対市場: ISR underperformed the Swedish Market which returned -6.8% over the past year.
価格変動
| ISR volatility | |
|---|---|
| ISR Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 9.3% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in SE Market | 11.4% |
| 10% least volatile stocks in SE Market | 3.2% |
安定した株価: ISR's share price has been volatile over the past 3 months.
時間の経過による変動: Insufficient data to determine ISR's volatility change over the past year.
会社概要
| 設立 | 従業員 | CEO（最高経営責任者 | ウェブサイト |
|---|---|---|---|
| 2007 | 5 | Ola Winqvist | israb.se |
ISR Immune System Regulation Holding AB (publ) 基礎のまとめ
| ISR 基礎統計学 | |
|---|---|
| 時価総額 | SEK 96.61m |
| 収益（TTM） | -SEK 213.05m |
| 売上高(TTM) | n/a |
0.0x
P/Sレシオ-0.5x
PER（株価収益率ISR は割高か？
公正価値と評価分析を参照収益と収入
| ISR 損益計算書（TTM） | |
|---|---|
| 収益 | SEK 0 |
| 売上原価 | SEK 0 |
| 売上総利益 | SEK 0 |
| その他の費用 | SEK 213.05m |
| 収益 | -SEK 213.05m |
直近の収益報告
Dec 31, 2022
次回決算日
該当なし
| 一株当たり利益（EPS） | -3.09 |
| グロス・マージン | 0.00% |
| 純利益率 | 0.00% |
| 有利子負債／自己資本比率 | -0.6% |
ISR の長期的なパフォーマンスは？
過去の実績と比較を見る